Adaptability costs in immune escape variants of vesicular stomatitis virus

Virus Research

Volumn 107, Issue 1, 2005, Pages 27-34

  Novella, Isabel S ^a,b   Gilbertson, Dorothy L ^b   Borrego, Belen ^c   Domingo, Esteban ^c   Holland, John J ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adaptability; Antibodies; Fitness; RNA virus; Trade off

Indexed keywords

NEUTRALIZING ANTIBODY; POLYCLONAL ANTISERUM; THROMBOSPONDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; ANTIGENIC VARIATION; ARTICLE; CELL MUTANT; CELL POPULATION; CELL STRAIN BHK; CONTROLLED STUDY; GENE MUTATION; HOST CELL; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGENY; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CRICETINAE; GENOTYPE; MEMBRANE GLYCOPROTEINS; MODELS, IMMUNOLOGICAL; MUTATION; NEUTRALIZATION TESTS; PHENOTYPE; VARIATION (GENETICS); VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 9644278116     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.06.007     Document Type: Article

References (50)

1. J.N. Barr, S.P.J. Whelan, and G.W. Wertz Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus Biochim. Biophys. Acta 1577 2002 323 353
2. A.M. Borman, S. Paulos, and F. Clavel Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug J. Gen. Virol. 77 1996 419 426
3. B. Borrego, I.S. Novella, E. Giralt, D. Andreu, and E. Domingo Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection J. Virol. 67 1993 6071 6079
4. C. Brander, and B.D. Walker Gradual adaptation of HIV to human host populations: good or bad news? Nat. Med. 9 2003 1359 1362
5. A.C. Brault, A.M. Powers, E.C. Holmes, C.H. Woelk, and S.C. Weaver Positively charged amino acid substitutions in E2 glycoprotein are associated with the emergence of Venezuelan equine encephalitis virus J. Virol. 76 2002 1718 1730
6. C. Burkhart, G. Freer, R. Castro, L. Adorini, K.-H. Wiesmuller, R.M. Zinkernagel, and H. Hengartner Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus J. Virol. 68 1994 1573 1580
7. W.F. Carman, A.R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, E. Tanzi, A.J. Zuckerman, and H.C. Thomas Vaccine-induced escape mutant of hepatitis B virus Lancet 336 1990 325 329
8. D.K. Clarke, E.A. Duarte, A. Moya, S.F. Elena, E. Domingo, and J. Holland Genetic bottlenecks and population passages cause profound fitness differences in RNA viruses J. Virol. 67 1993 222 228
9. J.M. Coffin HIV population dynamics in vivo-implications for genetic variation, pathogenesis and therapy Science 267 1995 483 489
10. J.A. Collins, M.G. Thompson, E. Paintsil, M. Ricketts, J. Gedzior, and L. Alexander Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants J. Virol. 78 2004 603 611
11. B.P. De, T. Das, and A.K. Banerjee Role of cellular kinases in the gene expression of nonsegmented negative strand RNA viruses Biol. Chem. 378 1997 489 493
12. E. Domingo, C. Biebricher, M. Eigen, and J. Holland Quasispecies and RNA Virus Evolution: Principles and Consequenes 2001 Landes Bioscience Georgetown, TX
13. E. Domingo, E. Martinez-Salas, F. Sobrino, J.C. delaTorre, A. Portela, J. Ortin, C. Lopez-Galindez, P. Perez-Brena, N. Villanueva, R. Najera, S. VandePol, D. Steinhauer, N. DePolo, and J. Holland The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance-a review Gene 40 1985 1 8
14. E.A. Duarte, I.S. Novella, S. Ledesma, D.K. Clarke, A. Moya, S.F. Elena, E. Domingo, and J.J. Holland Subclonal components of consensus fitness in an RNA virus clone J. Virol. 68 1994 4295 4301
15. S.F. Elena, and R.E. Lenski Evolution experiments with microorganims: the dynamics and genetic bases of adaptation Nat. Rev. Genet. 4 2003 457 469
16. R.T. Gandhi, A. Wurcel, E.S. Rosenberg, M.N. Johnston, N. Hellmann, M. Bates, M.S. Hirsch, and B.D. Walker Progressive reversion of human immunodeficiency virus type 1 resistance: mutations in vivo after transmission of a multiply drug-resistant virus Clin. Infect. Dis. 27 2003 1693 1698
17. J.J. Holland, J.C. de la Torre, and D.A. Steinhauer RNA virus populations as quasispecies Curr. Top. Microbiol. Immunol. 176 1992 1 20
18. J.J. Holland, J.C. de la Torre, D.C. Clarke, and E. Duarte Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses J. Virol. 65 1991 2960 2967
19. J.R. Kelley, S.U. Emerson, and R.R. Wagner The glycoprotein of vesicular stomatitis virus is the antigen that gives rise and reacts with neutralizing antibodies J. Virol. 10 1972 1231
20. R. Lambkin, L. MClain, S.E. Jones, S.L. Aldridge, and N.J. Dimmock Neutralization escape mutants of type-A influenza virus are readily selected by antisera from mice immunized with whole virus - a possible mechanism for antigenic drift J. Gen. Virol. 75 1994 3493 3502
21. L. Lefrancois, and D.S. Lyles The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. 1. Analysis of neutralizing epitopes with monoclonal antibodies Virology 121 1982 157 167
22. L. Lefrancois, and D.S. Lyles The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. 2. Monoclonal antibodies to non-neutralizing and cross-reactive epitopes of Indiana and New Jersey serotype Virology 121 1982 168 174
23. C. Liang, X. Li, L. Rong, P. Inouye, Y. Quan, L. Kleiman, and M.A. Wainberg The importance of the A-h loop in human immunodeficiency virus type 1 reverse transcription and infectivity J. Virol. 71 1977 5750 5757
24. S. Nagata, Y. Okamoto, T. Inoue, Y. Ueno, T. Kurata, and J. Chiba Identification of epitopes associated with different biological activities on the glycoprotein of vesicular stomatitis virus by use of monoclonal antibodies Arch. Virol. 127 1992 153 168
25. F. Ni, D. Fang, R. Gan, Z. Li, S. Duan, and Z. Xu A new immune escape mutant of hepatitis B virus with and Asp to Ala substitution in amino acid 144 of the envelope major protein Res. Virol. 146 1995 397 407
26. S.T. Nichol, J.E. Rowe, and W.M. Fitch Glycoprotein evolution of vesicular stomatitis virus New Jersey Virology 168 1989 281 291
27. M. Nijhuis, S. Deeks, and C. Boucher Implications of antiretroviral resistance on viral fitness Curr. Opin. Infect. Dis. 14 2001 23 28
28. I. Novella Contributions of vesicular stomatitis virus to the understanding of RNA virus evolution Curr. Opin. Microbiol. 6 2003 399 405
29. I.S. Novella, M. Cilnis, S.F. Elena, J. Kohn, A. Moya, E. Domingo, and J.J. Holland Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance J. Virol. 70 1996 6414 6417
30. I.S. Novella, E.A. Duarte, S.F. Elena, A. Moya, E. Domingo, and J.J. Holland Exponential increases of RNA virus fitness during large population transmissions Proc. Natl. Acad. Sci. U.S.A. 92 1995 5841 5844
31. A.M. Powers, M.S. Oberste, A.C. Brault, R. Rico-Hesse, S.M. Schmura, J.F. Smith, W.L. Kang, W.P. Sweeney, and S.C. Weaver Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus J. Virol. 71 1997 6697 6705
32. M.E. Quiñones-Mateu, M. Tadele, M. Parera, A. Mas, J. Weber, H.R. Rangel, B. Chakraborty, B. Clotet, E. Domingo, L. Menendez-Arias, and M.A. Martinez Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation J. Virol. 76 2002 10546 10552
33. L.L. Rodriguez, S.J. Pauszek, T.A. Bunch, and K.R. Schumann Full-length genome analysis of natural isolates of vesicular stomatitis virus (Indiana 1 serotype) from North, Central and South America J. Gen. Virol. 83 2002 2475 2483
34. J.H. Rose, and M.A. Whitt Rhabdoviridae and their replication fourth ed. D.M. Knipe P.M. Howley Field's Virology 1 2001 Lipicott Williams and Wilkins 1121 1244
35. Y.K. Shimizu, M. Hijikata, A. Iwamoto, H.J. Alter, R.H. Purcell, and H. Yoshikura Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses J. Virol. 68 1994 1494 1500
36. K.H.J. Siebelink, G.F. Rimmelzwaan, M.L. Bosch, R.H. Meloen, and A.D.M.E. Osterhaus A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization J. Virol. 67 1993 2202 2208
37. R. Skraban, S. Matthiasdottir, S. Torseinsdottir, G. Agnasdottir, B. Gudmundson, G. Georgsson, R.H. Meloen, O.S. Andresson, K.A. Staskus, H. Thormar, and V. ANdresdottir Naturally occurring mutations within the 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization epitope J. Virol. 73 1999 8064 8072
38. W.M. Sullender Respiratory syncytial virus genetic and antigenic diversity Clin. Microbiol. Rev. 13 2000 1 15
39. W.M. Sullender, and K.G. Edwards Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies Virology 264 1999 230 236
40. O. Taboga, C. Tami, E. Carrillo, J.I. Nunez, A. Rodriguez, J.C. Sainz, E. Blanco, M.L. Valero, X. Roig, J.A. Camarero, D. Andreu, M.G. Mateu, E. Giralt, E. Domingo, F. Sobrino, and E.L. Palma A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants J. Virol. 71 1997 2606 2614
41. M. Thali, M. Charles, C. Furman, L. Cavacini, M. Posner, J. Robinson, and J. Sodroski Resistantralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by gp41 amino acid change J. Virol. 68 1994 674 680
42. P.E. Turner, and S.F. Elena Cost of host radiation in an RNA virus Genetics 156 2000 1465 1470
43. S.B. VandePol, L. Lefrancois, and J.J. Holland Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus Virology 148 1986 312 325
44. L. VanValen A new evolutionary law Evol. Theory 1 1973 1 30
45. S.D. Vernon, L.L. Rodriguez, and G.J. Letchworth Vesicular stomatitis virus New jersey glysoprotein sequence and neutralizing epitope stability in an enzootic focus Virology 177 1990 209 215
46. W.A. Volk, R.M. Snyder, D.C. Benjamin, and R.W. Wagner Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity J. Virol. 42 1982 220 227
47. P.J. Walker, and K. Kongsuwan Deduced structural model for animal rhabdovirus glycoproteins J. Gen. Virol. 80 1999 1211 1220
48. B.A. Watkins, S. Buge, K. Aldrich, A.E. Davis, J. Robinson, M.S. Reitz, and M. Robert-Guroff Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites J. Virol. 70 1996 8431 8437
49. R.G. Webster Antigenic variation in influenza viruses E. Domingo R.G. Webster J.J. Holland Origin and Evolution of Viruses 1999 Academic Press 377 390
50. C.H. Woelk, and E.C. Holmes Reduced positive selection in vector-borne RNA viruses Mol. Biol. Evol. 19 2002 2333 2336